# Continental Vitamin Company Inc – FDA Inspection, Oct 26, 2017

Source: https://www.keypedia.com/records/fda_inspections/continental-vitamin-company-inc/1b82f06f-4f88-4a27-bb4a-a685c330ff15
Source feed: FDA_Inspections

> FDA inspection 1029902 of Continental Vitamin Company Inc, October 26, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029902
- Company Name: Continental Vitamin Company Inc
- Inspection Date: 2017-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Documents

- [FDA Inspection 1166241 - 2022-03-30](https://www.keypedia.com/records/fda_inspections/continental-vitamin-company-inc/8c4241e4-a96d-44a4-b959-8cbe67060d55)
- FDA Inspection 1056101 - 2018-04-30
- [FDA Inspection 829858 - 2013-04-02](https://www.keypedia.com/records/fda_inspections/continental-vitamin-company-inc/1b3161af-592f-4369-8352-3939ea04a9f3)

## Related Officers

- [Stephanie A. Slater](https://www.keypedia.com/people/stephanie-a-slater/f356e65c-3398-4688-8b86-4dcd4b9ae83b)

Company: https://www.keypedia.com/companies/continental-vitamin-company-inc/4083f968-af68-4de9-9ca8-5522baaa9446

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c